Navigation Links
MannKind Corporation to Review Positive Results From Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes
Date:12/15/2008

Live Broadcast on December 18, 2008 at 9 a.m. Eastern Time

VALENCIA, Calif., Dec. 15 /PRNewswire-FirstCall/ --MannKind Corporation (Nasdaq: MNKD) will host a live broadcast to review clinical results from its final two Phase 3 studies of AFRESA(TM), the company's ultra rapid acting, inhaled insulin product, at 9 a.m. Eastern Time on Thursday, December 18, 2008.

To participate in the live call by telephone, please dial (888) 677-5721 or (210) 839-8507. Those interested in viewing the live webcast via the Internet may do so by visiting the Company's website at http://www.mannkindcorp.com.

A telephone replay of the call will be accessible for approximately fourteen days following completion of the call by dialing (800) 873-5860 or (203) 369-3996. A replay will also be available on MannKind's website for fourteen days.

About AFRESA

Afresa is an ultra rapid acting inhaled insulin product that has completed Phase 3 trials. The pharmacokinetic profile of Afresa sets it apart from all other insulin products. The large surface area of the lung provides unique access to the circulatory system. The pH-sensitive Afresa particles immediately dissolve upon contact with the lung surface, releasing insulin monomers that rapidly enter the bloodstream. It achieves peak insulin levels within 12-14 minutes of administration, effectively mimicking the release of meal-time insulin observed in healthy individuals, but which is absent from patients with diabetes.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercializatio
'/>"/>

SOURCE MannKind Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. MannKind Reports Positive Data from a Phase 3 Clinical Study of Technosphere Insulin in Type 1 Diabetes
2. MannKind Addresses Pfizers Announcement Regarding Exubera
3. PDS Biotechnology Corporation Progresses Development of Nanotechnology Cancer Therapies
4. Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
5. Chemstar Corporation Announces a New Powerful, One-Step Product That Effectively Controls Listeria, Salmonella, E. coli and Fly Larvae in Floor Drains
6. Successful Results for Mymetics Corporations Mucosal HIV/AIDS Vaccine Viral Challenge Significantly Exceeds Expectations
7. National Jewish Health and Roche Diagnostics Corporation Reach Agreement to Pursue Environmental Molecular Diagnostics Opportunities
8. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
9. Genaera Corporation Presents Data on Mechanism of Inhibition of PTP-1B for Trodusquemine (MSI-1436) at Federation of American Societies for Experimental Biology (FASEB) Meeting
10. Genaera Corporation Presents Additional Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at American Diabetes Association
11. Atrium Medical Corporation Announces First Implant of First-in-Man CINATRA(TM) Voclosporin Coated Coronary Stent

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., CHICAGO, Nov. 27 At the upcoming...al meeting starting Sunday, Royal Philips Electron...of healthcare imaging and informatics solutions de...nts and care providers, by delivering meaningful i..., modular price points and easy upgradability. Th...
(Date:11/25/2009)... BEDFORD, Mass., Nov. 25 ...HOLX ), a leading developer, manufacturer and supp...ms and surgical products dedicated to serving the ...ting of the Radiological Society of North America ...through December 3, 2009 to highlight our new Secu...
(Date:11/25/2009)...DGEWATER, N.J., Nov. 25 The FDA gr...ravirine) tablets, a non-nucleoside reverse transc...NRTI specifically indicated for use in treatment-e...ailure with HIV-1 strains resistant to an NNRTI an...nal approval is based on 48-week data from two Pha...
Breaking Medicine Technology:Philips Helps Hospitals Strike Balance Between Innovation and Value 2Philips Helps Hospitals Strike Balance Between Innovation and Value 3Philips Helps Hospitals Strike Balance Between Innovation and Value 4New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5OAKWORKS Clinician Massage Table Product Line Gets a Green Makeover 58621 1OAKWORKS Clinician Massage Table Product Line Gets a Green Makeover 58621 2OAKWORKS Clinician Massage Table Product Line Gets a Green Makeover 58621 3OAKWORKS Clinician Massage Table Product Line Gets a Green Makeover 58621 4OAKWORKS Clinician Massage Table Product Line Gets a Green Makeover 58621 5OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer 3B Study Paves Way for Potential Registration 5118 1OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer 3B Study Paves Way for Potential Registration 5118 2OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer 3B Study Paves Way for Potential Registration 5118 3OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer 3B Study Paves Way for Potential Registration 5118 4OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer 3B Study Paves Way for Potential Registration 5118 5Smoking during pregnancy puts children at risk of psychotic symptoms 58612 1Smoking during pregnancy puts children at risk of psychotic symptoms 58612 2
(Date:11/27/2009)...ewswire/ -- Considered a highly risky and controve...rgan transplantation is now a life-saving mainstre...omen who gathered at the Winspear Opera House in D...al centers around the world to celebrate the 25th ...e (BRTI), one of the pioneers of solid organ trans...
(Date:11/27/2009)...v. 27 Team Garmin-Slipstream, the ... to ethical sporting and developing the next gener...t will become Team Garmin-Transitions with the add...he team. Transitions Optical is the world,s leadin...ost advanced photochromic technology in the widest...
(Date:11/27/2009)...les may reduce future disease burden, researchers ... -- Encouraging city dwellers to walk and bicycle ...lic health benefits than increased used of low-emi...The study compared the projected health effects in...s for London, England, and Delhi, India: business...
(Date:11/27/2009)...de; announced today that Spectrum Health (Grand Ra...ise orthopedic templating solution and its TraumaC... (PRWEB) November 27, 2009 -- Voyant Health&t...Rapids, Michigan) has licensed its TraumaCad Enter...aCad Extend workflow solution, to allow its orthop...
(Date:11/27/2009)...tive anatomy education apps from Modality and Lipp...es learning opportunities for iPhone and iPod touc...vember 27, 2009 -- Modality, Inc. and Lippincott...rs Kluwer Health, today announced the availability...ore. Clemente’s Anatomy, Rohen’s Photo...
Breaking Medicine News(10 mins):Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5
...icy drinks could make kids obese, says a new US st...een every two years// since age five by Alison K. ...e University, according to the online edition of h...actors that indicate a person could be headed towa...
...Henrik E. Poulsen and his colleagues of Copenhagen...ng plenty of olive oil in diet may help// in preve...ad to cancer. The results of their findings were r...it was found those who had 25 millilitres of olive...
...ted by dengue globally. Dengue is a viral disease ...ue shock syndrome is a fatal shock associated// wi...be any hemorrhage. The pathology of this disease i...specialists and their research partners (1) to foc...
...erit the risk to develop stroke than men, discover...d strokes// due to inadequate supply of blood to t...re studied by researchers. Studies revealed that t...n having mothers who also had a history of stroke,...
... predictions of influenza activity 2-4 weeks in ad... Diseases. // Though there are outbreaks of i... severity can be announced which would act as a ca...shares based on what they believe the likelihood o...
...assed a law to phase out the use of trans fat in r...cago, might follow suit. //According to Alice H. L...science and policy at the Friedman School of Nutri...th unsaturated fat. If they choose saturated fat i...
Other Medicine News:Health News:First Potential Treatment for Dengue 2Health News:The Outbreak of Influenza is Now Predicted 2Health News:Trans Fat Ban: Watch Saturated Fats and Calories Too 2Health News:Trans Fat Ban: Watch Saturated Fats and Calories Too 3
PAP Test
...e OR, how would you describe it? Would it maximize...e? Would its various components be flexible enough...? With ConMed Integrated Systems, you no longer ne...ay and it's called the Smart OR®. ,A complete...
...etic stimulator to offer the practical advantages ...esigned to provide the simplest operation possible...ame time, it may also help reduce patient anxiety ...ay from your patient). , ,Repetition rate and ...
...using Fractional Flow Reserve (FFR) is a,clinica...ning the functional,degree and location of steno...and RadiAnalyzer Xpress offer fast, easy and accur...evel of certainty to clinical decision-making., ...
Medicine Products: